Trials / Unknown
UnknownNCT03026452
Effectivity and Safety of Ultrasound-guided Percutaneously Radiofrequency Ablation for Liver Cancer
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- First Affiliated Hospital of Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and efficacy of ultrasonography (US) -guided radiofrequency ablation for liver tumors, the investigators used preoperative and postoperative US/CEUS(contrast-enhanced ultrasonography)/CT/MRI to assess lesions, and laboratory tests including the tumor markers to evaluate the general condition of patients. Intraoperative US/CEUS/CT would be applied to monitor ablation lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | US-guided RFA | The investigators used percutaneously US-guided radiofrequency ablation for patients with small hepatocellular carcinoma,and estimated the safety and efficacy of this treatment through 2-year follow-up of US/CEUS/CT/MRI and the tumor markers. |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2017-01-20
- Last updated
- 2018-07-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03026452. Inclusion in this directory is not an endorsement.